Bakkt Holdings
BKKT
Abits
ABTS
Digihost Technology
DGHI
Mawson Infrastructure
MIGI
CleanSpark
CLSK
US Stock MarketDetailed Quotes
CRVS Corvus Pharmaceuticals
- 4.470
- -0.230-4.89%
Trading Dec 19 09:42 ET
287.23MMarket Cap-4.52P/E (TTM)
4.670High4.450Low204.55KVolume4.670Open4.700Pre Close937.66KTurnover0.49%Turnover RatioLossP/E (Static)64.26MShares10.00052wk High23.16P/B186.50MFloat Cap1.30052wk Low--Dividend TTM41.72MShs Float22.137Historical High--Div YieldTTM4.68%Amplitude0.607Historical Low4.583Avg Price1Lot Size
About Corvus Pharmaceuticals Company
Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in Burlingame, CA.
Company Profile
SymbolCRVS
Company NameCorvus Pharmaceuticals
Listing DateMar 23, 2016
Issue Price15.00
Founded2014
CEODr. Richard A. Miller,M.D.
MarketNASDAQ
Employees28
Fiscal Year Ends12-31
Address863 Mitten Road,Suite 102
CityBurlingame
ProvinceCalifornia
CountryUnited States of America
Zip Code94010
Phone1-650-900-4520
Websitehttp://www.corvuspharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Richard A. Miller,M.D.
- President, Chief Executive Officer and Chairman of the Board
- 1.32M
- Jeffrey Arcara
- Senior Vice President and Chief Business Officer
- --
- Leiv Lea
- Chief Financial Officer and Principal Accounting Officer
- 660.76K
- William Benton Jones
- Senior Vice President, Pharmaceutical Development
- 616.26K
- Scott W. Morrison
- Independent Director
- 109.35K
- Ian T. Clark
- Independent Director
- 93.35K
- Dr. Linda S. Grais, J.D.,M.D.
- Independent Director
- 97.35K
- Dr. Peter A. Thompson,M.D.,F.A.C.P.
- Independent Director
- 95.35K
- Elisha P. Gould, III
- Independent Director
- 101.35K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.